FTSE All-Share
4.397,79
PKT
+93,95
PKT
+2,18
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.25 | GSK Hold | Deutsche Bank AG | |
| 06.02.25 | AstraZeneca Neutral | UBS AG | |
| 06.02.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 06.02.25 | BAT Buy | UBS AG | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Rio Tinto Neutral | UBS AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Outperform | Bernstein Research | |
| 05.02.25 | Diageo Sell | Deutsche Bank AG | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Sell | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Buy | UBS AG | |
| 03.03.25 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 05.02.25 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | Unilever Outperform | Bernstein Research | |
| 05.02.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 04.02.25 | Diageo Sector Perform | RBC Capital Markets | |
| 04.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 04.02.25 | Diageo Buy | UBS AG | |
| 04.02.25 | Vodafone Group Neutral | UBS AG | |
| 04.02.25 | Diageo Sell | Goldman Sachs Group Inc. | |
| 04.02.25 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 03.02.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 03.02.25 | Diageo Buy | Jefferies & Company Inc. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | HSBC Sector Perform | RBC Capital Markets | |
| 03.02.25 | Unilever Sell | UBS AG | |
| 03.02.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | HSBC Hold | Deutsche Bank AG | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. |